Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu

U.S. Food and Drug Administration Warnings

07/30/10   |   By

Shoulder Pain Pumps Destroy Shoulder Joints | DC Metro Area Medical Malpractice Law Blog

Recognized medical studies show that pain pumps that inject pain medicine right into shoulder joints after surgical procedures are a very likely cause of severe cartilage damage.  The FDA, in […]

Read More
07/11/10   |   By

FDA WARNING: Qualaquin unapproved for use for night leg cramps due to serious side effects | DC Metro Area Medical Malpractice L

The FDA issued a warning this week due to continued reports of serious side effects in patients using Qualaquin “off-label” for night time leg cramps. This medication is not intended […]

Read More
07/08/10   |   By

FDA WARNING: QUE SHE WEIGHT LOSS SUPPLEMENT CONTAINS DRUGS | DC Metro Area Medical Malpractice Law Blog

The FDA warned consumers and healthcare professionals today of the dangers of Que She, a capsule which was marketed as an herbal weight loss supplement but actually also “contains unlisted […]

Read More
06/10/10   |   By

FDA Warns Pfizer on failure to report drug complaints. | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, founding partner According to an AP report, the Food and Drug Administration issued a warning letter to “Pfizer I

Read More
01/09/10   |   By

FDA WARNING: NZU, A MORNING SICKENESS “REMEDY” MAY CONTAIN HIGH LEVELS OF LEAD/ARSENIC | DC Metro Area Medical Malprac

On December 31, 2009, the FDA issued a warning to consumers and medical professionals,to avoid consuming “Nzu”, a product taken as a traditional remedy for morning sickness due to high […]

Read More
06/12/09   |   By

FDA Warns of Dangers of Sirolimus (Rapamune) for Liver Transplant Patients | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire Recently, MedPage Today reported that “The FDA issued an alert regarding the risk of increased mortality in stable liver transplant patients who switch from […]

Read More
06/10/09   |   By

FDA Issues Warnings About Clarcon Skin Products | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire The AP recently reported that “The Food and Drug Administration warned consumers Monday not to use skin products made by Clarcon.” This warning followed […]

Read More
06/08/09   |   By

Atypical Antipsychotic Medications Effective But Risky for Children | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire According to the The Wall Street Journal, staff from the Food and Drug Administration (FDA) indicate that three medications “currently approved to treat bipolar […]

Read More
06/06/09   |   By

Propylthiouracil Poses Serious Liver Injury | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire An U.S. Department of Health and Human Services (HHS) report confirms that, two days ago, the U.S. Food and Drug Administration (FDA) “warned health […]

Read More
06/04/09   |   By

FDA May Require More Warnings on Tamoxifen Label | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire We recently posted a blog informing our readers that a Bloomberg report announced that researchers have determined that certain antidepressants may increase the recurrence […]

Read More

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top